Colchicine: Comment on “The Colchicine Debacle”
Abstract
The US drug approval system has 2 important goals: getting safe and effective drugs rapidly to patients and rewarding innovation in the pharmaceutical industry by offering market exclusivity for new drugs. Unfortunately, there are weaknesses in our current system, as illustrated by this article concerning colchicine. Offering market exclusivity in the 21st century for a drug that has been used for the treatment of gout since the 18th century, with randomized control trials confirming this...